...
首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Human neutral brush border endopeptidase EC 3.4.24.11 in urine, its isolation, characterisation and activity in renal diseases.
【24h】

Human neutral brush border endopeptidase EC 3.4.24.11 in urine, its isolation, characterisation and activity in renal diseases.

机译:人尿液中性刷状边界肽链内切酶EC 3.4.24.11在肾脏疾病中的分离,表征和活性。

获取原文
获取原文并翻译 | 示例

摘要

Human neutral brush border endopeptidase (NEP) was purified from the urine of patients suffering from acute toxic tubulointerstitial nephropathy. An enzyme preparation with specific activity of 102 Ug(-1) protein was obtained. The urinary activities of neutral endopeptidase and alanine aminopeptidase were measured in patients with renal disease and in 30 control patients, resulting in a reference range from 0.1 to 0.7 Ug(-1) creatinine and 1.4-14.1 Ug(-1) creatinine, respectively. Urine enzyme activities were highest in patients with acute tubulotoxic renal diseases. Neutral endopeptidase and alanine aminopeptidase activities were found to be 6.5- and 10-fold higher than the upper value of the reference range, respectively. Smaller increases in the rate of excretion of these enzymes (2.5- and 3.5-fold), respectively, were observed in patients suffering from acute tubular insufficiency and even lower increases, 2- and 1.5-fold, respectively, were observed in patients with chronic renal diseases. In diabetics and kidney transplant patients the enzyme excretion rates were within the reference range. Assay of both transmembrane metalloproteinases in urine may prove valuable in serving as markers for renal toxicity. Together with beta-NAG these enzymes could be employed as differentiation markers between acute and chronic tubular insufficiency.
机译:从患有急性中毒性肾小管间质性肾病的患者的尿液中纯化人中性刷状边界内肽酶(NEP)。获得了具有102 Ug(-1)蛋白比活的酶制剂。在肾病患者和30例对照患者中测量了中性内肽酶和丙氨酸氨基肽酶的尿活动,分别导致参考范围分别为0.1至0.7 Ug(-1)肌酐和1.4-14.1 Ug(-1)肌酐。急性肾小管毒性肾病患者的尿酶活性最高。发现中性内肽酶和丙氨酸氨基肽酶的活性分别比参考范围的上限高6.5和10倍。在患有急性肾小管供血不足的患者中,这些酶的排泄率分别增加较小(2.5倍和3.5倍),而在慢性患者中则观察到较低的增加,分别为2倍和1.5倍。肾脏疾病。在糖尿病和肾脏移植患者中,酶的排泄率在参考范围内。尿液中两种跨膜金属蛋白酶的测定在证明作为肾毒性的标志物方面可能是有价值的。这些酶与β-NAG一起可用作急性和慢性肾小管功能不全之间的区分标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号